Parametric Portfolio Associates’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-201,674
| Closed | -$17.1M | – | 4082 |
|
|
2019
Q4 | $17.1M | Sell |
201,674
-61,439
| -23% | -$4.1M | 0.01% | 1092 |
|
|
2019
Q3 | $13.2M | Buy |
263,113
+45,962
| +21% | +$1.83M | 0.01% | 1230 |
|
|
2019
Q2 | $7.92M | Buy |
217,151
+8,795
| +4% | +$287K | 0.01% | 1646 |
|
|
2019
Q1 | $5.82M | Buy |
208,356
+25,863
| +14% | +$610K | 0.01% | 1872 |
|
|
2018
Q4 | $3.49M | Buy |
182,493
+30,195
| +20% | +$702K | ﹤0.01% | 2167 |
|
|
2018
Q3 | $4.55M | Buy |
152,298
+34,019
| +29% | +$1.28M | ﹤0.01% | 2098 |
|
|
2018
Q2 | $4.34M | Sell |
118,279
-2,237
| -2% | -$72.7K | ﹤0.01% | 2072 |
|
|
2018
Q1 | $3.97M | Buy |
120,516
+7,506
| +7% | +$235K | ﹤0.01% | 2100 |
|
|
2017
Q4 | $3.09M | Sell |
113,010
-23,818
| -17% | -$734K | ﹤0.01% | 2291 |
|
|
2017
Q3 | $5.07M | Buy |
136,828
+12,580
| +10% | +$464K | 0.01% | 1818 |
|
|
2017
Q2 | $4.72M | Sell |
124,248
-27,686
| -18% | -$1.23M | 0.01% | 1827 |
|
|
2017
Q1 | $7.43M | Buy |
151,934
+34,407
| +29% | +$1.57M | 0.01% | 1398 |
|
|
2016
Q4 | $3.99M | Sell |
117,527
-18,102
| -13% | -$642K | 0.01% | 1869 |
|
|
2016
Q3 | $5.12M | Sell |
135,629
-6,472
| -5% | -$244K | 0.01% | 1546 |
|
|
2016
Q2 | $4.78M | Buy |
142,101
+2,669
| +2% | +$94.1K | 0.01% | 1570 |
|
|
2016
Q1 | $4.43M | Buy |
139,432
+10,823
| +8% | +$353K | 0.01% | 1686 |
|
|
2015
Q4 | $4.8M | Buy |
128,609
+13,429
| +12% | +$508K | 0.01% | 1412 |
|
|
2015
Q3 | $4.37M | Buy |
115,180
+11,390
| +11% | +$400K | 0.01% | 1227 |
|
|
2015
Q2 | $2.97M | Buy |
103,790
+1,951
| +2% | +$54.3K | 0.01% | 1869 |
|
|
2015
Q1 | $2.85M | Buy |
101,839
+5,789
| +6% | +$163K | 0.01% | 1887 |
|
|
2014
Q4 | $2.66M | Buy |
96,050
+13,194
| +16% | +$327K | 0.01% | 1891 |
|
|
2014
Q3 | $1.85M | Buy |
82,856
+12,411
| +18% | +$315K | ﹤0.01% | 2153 |
|
|
2014
Q2 | $2.05M | Sell |
70,445
-4,471
| -6% | -$119K | ﹤0.01% | 2067 |
|
|
2014
Q1 | $2.13M | Sell |
74,916
-746
| -1% | -$24.7K | 0.01% | 1995 |
|
|
2013
Q4 | $2.92M | Buy |
75,662
+11,223
| +17% | +$401K | 0.01% | 1649 |
|
|
2013
Q3 | $2.16M | Buy |
64,439
+3,451
| +6% | +$110K | 0.01% | 1871 |
|
|
2013
Q2 | $1.88M | Buy |
+60,988
| New | +$2.04M | 0.01% | 1879 |
|
Other funds holding MDCO
Parametric Portfolio Associates's MDCO Position: Q1 2020 in Review
Parametric Portfolio Associates sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 201,674 shares — an estimated $17.1M sold.
Parametric Portfolio Associates first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $17.1M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Parametric Portfolio Associates reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Parametric Portfolio Associates sold 201,674 Medicines Co shares in Q1 2020, an estimated $17.1M.
- Parametric Portfolio Associates first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Parametric Portfolio Associates's Medicines Co position peaked at $17.1M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Parametric Portfolio Associates's 13F filing for Q1 2020, filed 13 May 2020.